The biotechnology industry is still a growth industry. Investing in an ETF gives me exposure to an industry I don't fully understand. The two major ETFs in the industry have different portfolio ...

DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While ...

View post: Macy's is selling a $150 luxe faux fur throw for only $30 as the perfect holiday gift Biotech stories typically tread a very fine line between promise and pressure. Sometimes a company that ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

After being mostly down over the past three years, the biotech sector rallied hard to end 2023. The SPDR S&P Biotech ETF (NYSEARCA:XBI) is up 31% in the last three months. From 2010 through 2019, ...

The latest announcement is out from Viva Biotech Holdings ( (HK:1873) ).

For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...

Strong manufacturing base a driving force behind overseas expansion, but industry leaders and analysts say hurdles remain.